Leonabio, Inc. · NASDAQ:LONA
Baselake Partners, LP's stake in Leonabio, Inc. fell to 1.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 6, 2026
Baselake Partners, LP's stake in Leonabio, Inc. fell to 1.90%, 75,789 shares, as a passive investor on Dec 31, 2025. Filed Feb 6, 2026 (Schedule 13G/A).
- Stake
- 1.90%
- Shares
- 75,789
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baselake Partners, LP | 1.90% | 75,789 |
| Baselake Management, LLC | 1.90% | 75,789 |
| David Paolella | 1.90% | 75,789 |
Source
Related
- Leonabio, Inc.
- Baselake Partners, LP
- Leonabio, Inc. shareholders
- Schedule 13G · Baselake Partners, LP · Nov 14, 2025
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026